MedTrace Logo

RESOLUTE ONYX Post-Approval Study

NCT03063749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 416

Last updated 2023-11-22

No results posted yet for this study

Summary

To observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.

Conditions

Interventions

DEVICE

Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 2.0 mm - 4.0 mm

DEVICE

Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 4.5 mm - 5.0 mm

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2018-10-20
Completion
2022-08-18

Countries

  • United States
  • Belgium
  • France
  • Slovakia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063749 on ClinicalTrials.gov